Director Robert Hofmeister resigns from Alaunos Therapeutics board effective April 15, 2025

Alaunos Therapeutics, Inc.

Robert Hofmeister, Ph.D., resigned from the board with immediate effect on April 15, 2025.
Resignation was not due to any disagreement on operations, policies, or practices.
No replacement has been named by the company.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Hofmeister

director

TCRT · Alaunos Therapeutics, Inc.

Effective: 2025-04-15
Filed: April 18, 2025, 7:59 PM ET

Robert Hofmeister, Ph.D. Resignation On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert Hofmeister resigned as director at Alaunos Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

Robert Hofmeister, Ph.D. Resignation On April 15, 2025, Dr. Hofmeister resigned as a member of the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) with immediate effect.

View on SEC.gov

Alaunos Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-055903

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.